Oftalmolosa Cusí Cloramfenicol (Chloramphenicol)

Chloramphenicol, the active ingredient in Oftalmolosa Cusí Cloramfenicol, is an antibiotic presented as a ophthalmic preparation for topical eye use. It treats bacterial eye infections such as conjunctivitis and keratitis in adults and children. GNH USA supplies Oftalmolosa Cusí Cloramfenicol as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Oftalmolosa Cusí Cloramfenicol as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Oftalmolosa Cusí Cloramfenicol is an ophthalmic antibiotic used to manage bacterial infections of the eye surface.

- Conjunctivitis: reduces bacterial load and alleviates redness and discharge. - Keratitis: helps eradicate causative bacteria and promotes corneal healing. - Blepharitis: controls bacterial overgrowth on eyelid margins. - Post‑surgical prophylaxis: prevents infection after ocular surgery. - Trachoma management: part of community‑based treatment programmes.

Adverse reactions to ophthalmic chloramphenicol are generally mild and localized.

Common Side Effects: - Burning sensation: mild transient burning upon instillation. - Stinging: brief stinging feeling in the eye. - Redness: mild conjunctival hyperemia. - Tearing: increased lacrimation. - Foreign‑body sensation: feeling of grit or sand. - Itching: mild ocular itching.

Serious or Rare Side Effects: - Allergic contact dermatitis: localized skin reaction around the eye. - Stevens‑Johnson syndrome: rare severe mucocutaneous reaction. - Anaphylaxis: acute systemic allergic response. - Corneal ulceration: rare worsening of corneal integrity. - Vision loss: extremely rare, may be related to severe adverse reaction. - Bone marrow suppression: systemic effect if absorbed in large amounts, very rare.

When using ophthalmic chloramphenicol, follow safety guidelines to minimise risks.

- Indications check: confirm bacterial eye infection before use. - Duration of therapy: limit to the prescribed period, typically not exceeding 7‑7 days. - Contact lens wearers: remove lenses before instillation and wait before reinserting. - Systemic absorption: avoid excessive use to reduce risk of systemic toxicity. - Pregnancy and lactation: use only if clearly needed and prescribed by a healthcare professional. - Store at ambient temperature: keep in the original container, protect from light and moisture.

Chloramphenicol eye drops have limited systemic drug interactions, but caution is advised.

Major Interactions (Avoid): - Systemic aminoglycosides: concurrent use may increase risk of ototoxicity. - Systemic anticoagulants: may potentiate bleeding risk if significant systemic absorption occurs.

Moderate Interactions (Monitor Closely): - Other topical ophthalmic antibiotics: may affect local flora balance. - Non‑steroidal anti‑inflammatory eye drops: monitor for additive irritation. - Systemic corticosteroids: watch for delayed wound healing. - Antifungal eye preparations: assess for antagonistic effects.